Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance

Am J Transplant. 2009 Jun;9(6):1460-6. doi: 10.1111/j.1600-6143.2009.02651.x. Epub 2009 May 20.

Abstract

To better understand the implications for considering delayed graft function (DGF) as a performance measure, we compared outcomes associated with a 2- to 3-fold difference in the incidence of DGF at two transplant centers. We analyzed 5072 kidney transplantations between 1984 and 2006 at the University of Minnesota Medical Center (UMMC) and Hennepin County Medical Center (HCMC). In logistic regression the adjusted odds ratio for DGF at HCMC versus UMMC was 3.11 (95% Confidence Interval [CI]= 2.49-3.89) for deceased donors and 2.24 (CI = 1.45-3.47) for living donors. In Cox analysis of 4957 transplantations, slow graft function (SGF; creatinine >or=3.0 mg/dL [230 micromol/L] on day 5 without dialysis) was associated with graft failure at UMMC (Relative Risk [RR]= 1.43, CI = 1.25-1.64), but not HCMC (RR = 0.99, CI = 0.77-1.28). RR's of DGF were similar at both centers. Thus, the lower incidence of DGF at UMMC likely resulted in a higher incidence and higher risk of SGF compared to HCMC. Indeed, graft survival for recipients with DGF at HCMC was similar (p = 0.3741) to that of recipients with SGF at UMMC. We conclude that dialysis per se is likely not a cause of worse graft outcomes. A better definition is needed to measure early graft dysfunction and its effects across transplant programs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Creatinine / blood
  • Delayed Graft Function / epidemiology*
  • Graft Rejection / epidemiology
  • Graft Rejection / mortality
  • Graft Survival
  • Humans
  • Kidney Function Tests
  • Kidney Transplantation / statistics & numerical data*
  • Minnesota / epidemiology
  • Outcome and Process Assessment, Health Care
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Renal Dialysis / statistics & numerical data*
  • Retrospective Studies
  • Risk
  • Treatment Outcome

Substances

  • Creatinine